Targeted extracellular degradation of LRP8 promotes ferroptosis in cancer cells
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2616933123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Fangzhu Zhao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA 94158. Hauptthemen laut MEDLINE: Ferroptosis, LDL-Receptor Related Proteins, Neoplasms, Tumor Suppressor Proteins. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, HHS | NIH | National Cancer Institute (NCI), NCI NIH HHS.
Abstract (Originalsprache)
Tumor reliance on antioxidant defenses creates a vulnerability to ferroptosis, yet strategies to therapeutically disable these systems remain limited. Here, we identify targeted degradation of the selenium uptake receptor lipoprotein receptor-related protein 8 (LRP8) as an effective approach to decrease the abundance of the ferroptosis-protective enzyme glutathione peroxidase 4 (GPX4). Using bispecific cytokine receptor–targeting chimeras (KineTACs) that couple LRP8 to cytokine receptor internalization pathways, we selectively direct LRP8 to the lysosome for degradation. LRP8 degradation reduces the abundance of several selenoproteins, including GPX4, lowering the cellular threshold for lipid peroxidation and sensitizing cancer cells to ferroptosis. These findings establish receptor-mediated selenium uptake as a critical, targetable node in ferroptosis resistance and demonstrate that extracellular protein degradation can be leveraged to reprogram intracellular translational dependencies in cancer cells. More broadly, this work provides a framework for exploiting nutrient acquisition pathways to overcome therapy resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA 94158.
- Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA 94720.
- Department of Metabolic Biology and Nutrition, University of California Berkeley, Berkeley, CA 94720.
- Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA 94158.
ORCID-Profile: Fangzhu Zhao, Alex Inague, Trenton M Peters-Clarke, Yifei Chen, Yan Wu, Madison K C Seto, Kevin K Leung, James A Olzmann, James A Wells
Förderung
- NIGMS NIH HHS
- HHS | NIH | National Cancer Institute (NCI)
- NCI NIH HHS
- NSF | NSF Graduate Research Fellowship Program (GRFP)
- HHS | NIH | National Institute of General Medical Sciences (NIGMS)
Zitieren
APA
Zhao, F., Inague, A., Peters-Clarke, T. M., Chen, Y., Ganjave, S. D., Zhang, Y., Miao, K., Yao, Z., Wu, Y., Seto, M. K. C., Leung, K. K., Olzmann, J. A., & Wells, J. A. (2026). Targeted extracellular degradation of LRP8 promotes ferroptosis in cancer cells. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2616933123
Vancouver
Zhao F, Inague A, Peters-Clarke TM, Chen Y, Ganjave SD, Zhang Y, et al. Targeted extracellular degradation of LRP8 promotes ferroptosis in cancer cells. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2616933123
BibTeX
@article{Zhao2026,
author = {Zhao, Fangzhu and Inague, Alex and Peters-Clarke, Trenton M and Chen, Yifei and Ganjave, Snehal D and Zhang, Yun and Miao, Kun and Yao, Zi and Wu, Yan and Seto, Madison K C and Leung, Kevin K and Olzmann, James A and Wells, James A},
title = {Targeted extracellular degradation of LRP8 promotes ferroptosis in cancer cells},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2616933123}
}
EUVIMED